Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1973 1
1975 2
1977 1
1982 1
1984 2
1985 2
1987 2
1988 5
1989 7
1990 5
1991 4
1992 7
1993 6
1994 1
1997 1
1998 1
2000 1
2002 2
2003 4
2004 4
2005 1
2006 4
2007 10
2008 7
2009 8
2010 2
2011 4
2012 5
2013 4
2014 6
2015 1
2016 1
2017 3
2018 3
2019 2
2020 4
2021 7
2022 6
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations From the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS).
Shander A, Corwin HL, Meier J, Auerbach M, Bisbe E, Blitz J, Erhard J, Faraoni D, Farmer SL, Frank SM, Girelli D, Hall T, Hardy JF, Hofmann A, Lee CK, Leung TW, Ozawa S, Sathar J, Spahn DR, Torres R, Warner MA, Muñoz M. Shander A, et al. Ann Surg. 2023 Apr 1;277(4):581-590. doi: 10.1097/SLA.0000000000005721. Epub 2022 Sep 21. Ann Surg. 2023. PMID: 36134567 Free PMC article.
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.
Wang TY, Wahed AS, Morris A, Kreuziger LB, Quigley JG, Lamas GA, Weissman AJ, Lopez-Sendon J, Knudson MM, Siegal DM, Kasthuri RS, Alexander AJ, Wahid L, Atassi B, Miller PJ, Lawson JW, Patel B, Krishnan JA, Shapiro NL, Martin DE, Kindzelski AL, Leifer ES, Joo J, Lyu L, Pennella A, Everett BM, Geraci MW, Anstrom KJ, Ortel TL; ACTIV-4C Study Group. Wang TY, et al. Ann Intern Med. 2023 Apr;176(4):515-523. doi: 10.7326/M22-3350. Epub 2023 Mar 21. Ann Intern Med. 2023. PMID: 36940444 Free PMC article. Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Adrenal Neoplasms: Lessons from Adrenal Multidisciplinary Tumor Boards.
Chung R, Garratt J, Remer EM, Navin P, Blake MA, Taffel MT, Hackett CE, Sharbidre KG, Tu W, Low G, Bara M, Carney BW, Corwin MT, Campbell MJ, Lee JT, Lee CY, Dueber JC, Shehata MA, Caoili EM, Schieda N, Elsayes KM. Chung R, et al. Radiographics. 2023 Jul;43(7):e220191. doi: 10.1148/rg.220191. Radiographics. 2023. PMID: 37347698
Advances and prospects for the Human BioMolecular Atlas Program (HuBMAP).
Jain S, Pei L, Spraggins JM, Angelo M, Carson JP, Gehlenborg N, Ginty F, Gonçalves JP, Hagood JS, Hickey JW, Kelleher NL, Laurent LC, Lin S, Lin Y, Liu H, Naba A, Nakayasu ES, Qian WJ, Radtke A, Robson P, Stockwell BR, Van de Plas R, Vlachos IS, Zhou M; HuBMAP Consortium; Börner K, Snyder MP. Jain S, et al. Nat Cell Biol. 2023 Aug;25(8):1089-1100. doi: 10.1038/s41556-023-01194-w. Epub 2023 Jul 19. Nat Cell Biol. 2023. PMID: 37468756 Free PMC article. Review.
A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT.
Hong CW, Chernyak V, Choi JY, Lee S, Potu C, Delgado T, Wolfson T, Gamst A, Birnbaum J, Kampalath R, Lall C, Lee JT, Owen JW, Aguirre DA, Mendiratta-Lala M, Davenport MS, Masch W, Roudenko A, Lewis SC, Kierans AS, Hecht EM, Bashir MR, Brancatelli G, Douek ML, Ohliger MA, Tang A, Cerny M, Fung A, Costa EA, Corwin MT, McGahan JP, Kalb B, Elsayes KM, Surabhi VR, Blair K, Marks RM, Horvat N, Best S, Ash R, Ganesan K, Kagay CR, Kambadakone A, Wang J, Cruite I, Bijan B, Goodwin M, Moura Cunha G, Tamayo-Murillo D, Fowler KJ, Sirlin CB. Hong CW, et al. Radiology. 2023 Jun;307(5):e222855. doi: 10.1148/radiol.222855. Radiology. 2023. PMID: 37367445
Receptor-mediated inotropic drugs.
van Zwieten PA. van Zwieten PA. Eur Heart J. 1988 Jun;9 Suppl H:85-90. doi: 10.1093/eurheartj/9.suppl_h.85. Eur Heart J. 1988. PMID: 2901958 Review.
After a general survey of cardiac beta- and alpha-adrenoreceptors and of dopaminergic receptors in the cardiovascular system, the following receptor-mediated inotropic drugs are discussed: isoprenaline, dobutamine, xamoterol, pirbuterol, terbutaline, salbutamol, dopamine, …
After a general survey of cardiac beta- and alpha-adrenoreceptors and of dopaminergic receptors in the cardiovascular system, the following …
The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
Virk SJ, Anfilogoff NH, Lawson N, Sadler AM, Smith SJ, Nuttall A, Murray RG, Littler WA, Davies MK. Virk SJ, et al. Eur Heart J. 1989 Mar;10(3):227-34. doi: 10.1093/oxfordjournals.eurheartj.a059470. Eur Heart J. 1989. PMID: 2565233
The known properties of xamoterol, a partial beta 1-agonist, provide a basis to pharmacologically modulate cardiac responses to variations in sympathetic tone. ...Xamoterol produced significant improvements in resting cardiac index (2.51 +/- 0.15 to 2.80 +/- 0.14 …
The known properties of xamoterol, a partial beta 1-agonist, provide a basis to pharmacologically modulate cardiac responses to varia …
143 results